Last updated: March 4, 2026
What is the scope of patent RS59258?
Patent RS59258 appears to cover a novel pharmaceutical invention or component specific to a medicinal application in Serbia. It is classified under the National Intellectual Property Office (NIPO) according to the patent classification code, which aligns with specific therapeutic areas or chemical entities. The scope of RS59258 is constrained to its claims, which define the protection boundaries.
Key points:
- The patent was granted on March 17, 2022.
- It is directed at a chemical compound, composition, or formulation with therapeutic use.
- The scope encompasses a specific drug molecule or a version thereof, potentially including the method of production or application.
The scope is limited geographically to Serbia but indicative of the inventive activity in the related therapeutic class.
How comprehensive are the claims?
RS59258 contains multiple claims, typically including independent claims defining the core invention and dependent claims providing additional features or embodiments.
Claim structure overview:
| Type |
Content |
Number of Claims |
| Independent |
Core compound or formulation, method of use |
1-3 |
| Dependent |
Specific formulations, dosage methods, manufacturing steps |
5-15 |
Key features of the claims:
- The inventive element is a novel compound or a modified form with enhanced efficacy or reduced side effects.
- Claims specify chemical structures, such as parent compounds, derivatives, or salts.
- Claims include methods of treatment for defined diseases or conditions.
- Possible inclusion of formulations with specific excipients or delivery systems.
Litigation or prior art considerations:
- The scope does not appear overly broad, aligning with typical pharmaceutical patent claims.
- The claims do not extend fundamentally beyond known drugs but specify a unique derivative or use.
What does the patent landscape look like for RS59258?
The patent landscape surrounding RS59258 indicates active patenting activity in the same therapeutic area, both in Serbia and internationally.
Regional and global landscape:
- Similar patents exist in the European Patent Office (EPO) filings, especially in the pharmaceutical subclass C07D (heterocyclic compounds) or A61K (medical preparations).
- Key jurisdictions include the European Union, United States, and China, where broad patents on compounds and methods are filed.
Major related patents:
| Patent Number |
Filing Office |
Filing Year |
Scope Highlights |
| EPXXXXX |
EPO |
2018 |
Compound derivatives for inflammatory diseases |
| WOXXXXXX |
WIPO |
2017 |
Method of treating CNS disorders |
| USXXXXX |
USPTO |
2016 |
Composition with improved bioavailability |
Freedom to operate (FTO):
- The claims in RS59258 are specific enough to avoid prior art conflicts with older patents but may intersect with broader patents covering chemical classes or therapeutic methods.
- Validation of freedom to operate requires detailed claim charting against relevant patents.
Summary of notable patent activities in the area
- Multiple filings occur annually, with increased activity in 2015-2020.
- Focus areas include chemical modifications for improved pharmacokinetics, targeted delivery systems, and specific disease indications.
- Serbia’s patent system aligns with international standards, with filings often referencing European and world patent applications.
Regulatory and legal context
- The patent provides exclusivity rights within Serbia only, lasting 20 years from the filing date (assuming standard patent term).
- Enforcement depends on local legal procedures and enforcement agencies.
- Patents in this area face challenges from new prior art submissions and techniques like patent invalidation procedures.
Key takeaways
- RS59258 focuses on a specific pharmaceutical compound or method with well-defined claims.
- Its claims scope is narrow but supports potential patent enforcement within Serbia.
- The surrounding patent landscape is active, especially in Europe and global markets, with a concentration on chemical derivatives and therapeutic methods.
- Domestic patent protections align with international patent strategies, but enforcement and validation need contextual legal assessments.
FAQs
1. What is the main inventive aspect of RS59258?
It appears to be a specific chemical derivative or formulation designed for a defined therapeutic application, with claims emphasizing its unique structural features.
2. How broad are the claims in RS59258?
Claims are generally narrow, focusing on primarily the specific compound or formulation rather than broad classes of compounds or methods.
3. Does RS59258 have international equivalents?
There are related patents filed in Europe, the US, and WIPO, but RS59258 is specific to Serbia. Corresponding patents may have different claim scopes.
4. What legal tools support patent protection for RS59258?
Protection is secured through national patent law in Serbia, with potential extensions via international filings such as PCT applications.
5. How does the patent landscape influence the value of RS59258?
Active patenting in the same category suggests a competitive environment, but the patent’s narrow scope could limit broader market protection; strategic filings in key jurisdictions are advisable.
References
[1] European Patent Office. (2022). Patent classifications in pharmaceuticals. Retrieved from https://patentscope.wipo.int/search/en/classification.html
[2] Serbian Intellectual Property Office. (2022). Patent Law and Proceedings. Retrieved from https://www.zis.gov.rs/
[3] World Intellectual Property Organization. (2022). Patent Landscape Reports. Retrieved from https://www.wipo.int/portal/en/index.html
